Compounds > diltiazem
Page last updated: 2024-08-23

diltiazem and Carcinoma, Hepatocellular

diltiazem has been researched along with Carcinoma, Hepatocellular in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, R; Huang, X; Jin, X; Li, Z; Tian, Y; Yang, J1
Baumann, H; Jahreis, GP; Rose, S; Sayeed, MM1
Behnke, B; Gebhardt, A; Naegele, H; Strohbeck, M1
Corsini, A; Fumagalli, R; Granata, A; Paoletti, R1

Other Studies

4 other study(ies) available for diltiazem and Carcinoma, Hepatocellular

ArticleYear
[Calcium channel blocker diltizem transiently inhibits migration and up-regulates metadherin expression in hepatocellular carcinoma cells
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2019, Mar-30, Volume: 39, Issue:3

    Topics: Calcium Channel Blockers; Carcinoma, Hepatocellular; Cell Line, Tumor; Diltiazem; Humans; Liver Neoplasms

2019
Diltiazem and superoxide dismutase modulate hepatic acute phase response in gram-negative sepsis.
    Shock (Augusta, Ga.), 1994, Volume: 1, Issue:2

    Topics: Acute-Phase Proteins; Acute-Phase Reaction; Animals; Bacteroides fragilis; Bacteroides Infections; Blood Proteins; Calcium; Carcinoma, Hepatocellular; Diltiazem; Escherichia coli Infections; Gene Expression Regulation; Gram-Negative Bacterial Infections; Interleukin-1; Interleukin-6; Liver; Liver Neoplasms; Male; Neoplasm Proteins; Peritonitis; Rats; Rats, Sprague-Dawley; Sepsis; Superoxide Dismutase; Tumor Cells, Cultured; Verapamil

1994
Effects of antihypertensive drugs on cholesterol metabolism of human mononuclear leukocytes and hepatoma cells.
    Clinical biochemistry, 1998, Volume: 31, Issue:1

    Topics: Antihypertensive Agents; Carcinoma, Hepatocellular; Cholesterol; Diltiazem; Humans; Leukocytes, Mononuclear; Liver Neoplasms; Metoprolol; Nifedipine; Propranolol; Tumor Cells, Cultured; Verapamil

1998
Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2.
    Pharmacological research communications, 1986, Volume: 18, Issue:1

    Topics: Amanitins; Biotransformation; Calcium Channel Blockers; Carcinoma, Hepatocellular; Cell Line; Cycloheximide; Diltiazem; Fibroblasts; Humans; Lipoproteins; Lipoproteins, LDL; Liver Neoplasms; Papaverine; Receptors, LDL; Verapamil

1986